- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Tatva Chintan Pharma Chem Limited — Board Meeting, 21-01-2026: Outcome of Board Meeting
21-01-2026 | 03:52 pm
21-01-2026 | 03:52 pm
Tatva Chintan's Board approved the consolidated financial results for the quarter and nine months ended December 31, 2025. Q3 revenue reached ₹131.33 Cr, with profit at ₹15.17 Cr. For the nine months, revenue stood at ₹371.70 Cr and profit at ₹31.73 Cr.
No comments yet. Be the first to comment!